<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31442225</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections.</ArticleTitle><Pagination><StartPage>e0007649</StartPage><MedlinePgn>e0007649</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0007649</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0007649</ELocationID><Abstract><AbstractText>The explosive spread of Zika virus (ZIKV) and associated complications in flavivirus-endemic regions underscore the need for sensitive and specific serodiagnostic tests to distinguish ZIKV, dengue virus (DENV) and other flavivirus infections. Compared with traditional envelope protein-based assays, several nonstructural protein 1 (NS1)-based assays showed improved specificity, however, none can detect and discriminate three flaviviruses in a single assay. Moreover, secondary DENV infection and ZIKV infection with previous DENV infection, both common in endemic regions, cannot be discriminated. In this study, we developed a high-throughput and multiplex IgG microsphere immunoassay (MIA) using the NS1 proteins of DENV1-DENV4, ZIKV and West Nile virus (WNV) to test samples from reverse-transcription-polymerase-chain reaction-confirmed cases, including primary DENV1, DENV2, DENV3, WNV and ZIKV infections, secondary DENV infection, and ZIKV infection with previous DENV infection. Combination of four DENV NS1 IgG MIAs revealed a sensitivity of 94.3% and specificity of 97.2% to detect DENV infection. The ZIKV and WNV NS1 IgG MIAs had a sensitivity/specificity of 100%/87.9% and 86.1%/78.4%, respectively. A positive correlation was found between the readouts of enzyme-linked immunosorbent assay and MIA for different NS1 tested. Based on the ratio of relative median fluorescence intensity of ZIKV NS1 to DENV1 NS1, the IgG MIA can distinguish ZIKV infection with previous DENV infection and secondary DENV infection with a sensitivity of 88.9-90.0% and specificity of 91.7-100.0%. The multiplex and high-throughput assay could be applied to serodiagnosis and serosurveillance of DENV, ZIKV and WNV infections in endemic regions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyson</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Wen-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Jih-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe4;ssg&#xe5;rd</LastName><ForeName>Ludvig</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stramer</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>American Red Cross Scientific Support Office, Gaithersburg, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehrer</LastName><ForeName>Axel T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nerurkar</LastName><ForeName>Vivek R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Kung</ForeName><Initials>WK</Initials><Identifier Source="ORCID">0000-0002-6670-4663</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI110769</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI135292</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008863" MajorTopicYN="Y">Microspheres</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014901" MajorTopicYN="N">West Nile Fever</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31442225</ArticleId><ArticleId IdType="pmc">PMC6707547</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0007649</ArticleId><ArticleId IdType="pii">PNTD-D-19-00709</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika Virus. N Engl J Med. 2016; 374:1552&#x2013;1563. 10.1056/NEJMra1602113</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1602113</ArticleId><ArticleId IdType="pubmed">27028561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Diamond MS. The emergence of Zika virus and its new clinical syndromes. Nature. 2018;560:573&#x2013;581. 10.1038/s41586-018-0446-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0446-y</ArticleId><ArticleId IdType="pubmed">30158602</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauer F, Riesen M, Reveiz L, Oladapo OT, Mart&#xed;nez-Vega R, Porgo TV, et al. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barr&#xe9; syndrome: systematic review. PLoS Med. 2017;14:e1002203 10.1371/journal.pmed.1002203</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002203</ArticleId><ArticleId IdType="pmc">PMC5207634</ArticleId><ArticleId IdType="pubmed">28045901</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. An update on Zika virus infection. Lancet. 2017;390:2099&#x2013;2109. 10.1016/S0140-6736(17)31450-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31450-2</ArticleId><ArticleId IdType="pubmed">28647173</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidance for U.S. Laboratories Testing for Zika Virus Infection. From CDC&#x2019;s website: http://www.cdc.gov/zika/laboratories/lab-guidance.html.</Citation></Reference><Reference><Citation>Rabe IB, Staples JE, Villanueva J, Hummel KB, Johnson JA, Rose L, et al. Interim Guidance for Interpretation of Zika Virus Antibody Test Results. MMWR Morb Mortal Wkly Rep. 2016;65:543&#x2013;546. 10.15585/mmwr.mm6521e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6521e1</ArticleId><ArticleId IdType="pubmed">27254248</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L, et al. Persistence of Zika Virus in Body Fluids&#x2014;Preliminary Report. N Engl J Med. 2018; 379:1234&#x2013;1243. 10.1056/NEJMoa1613108</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1613108</ArticleId><ArticleId IdType="pmc">PMC5831142</ArticleId><ArticleId IdType="pubmed">28195756</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis. 2011;17:880&#x2013;882. 10.3201/eid1705.101939</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1705.101939</ArticleId><ArticleId IdType="pmc">PMC3321795</ArticleId><ArticleId IdType="pubmed">21529401</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks RB, Carlos MP, Myers RA, White MG, Bobo-Lenoci T, Aplan D, et al. Likely Sexual Transmission of Zika Virus from a Man with No Symptoms of Infection&#x2014;Maryland, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:915&#x2013;916. 10.15585/mmwr.mm6534e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6534e2</ArticleId><ArticleId IdType="pubmed">27585037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Diamond MS. 2013. Flaviviruses Knipe DM, Howley PM, eds. Fields virology, 6th ed, Philadelphia: Lippincott William &amp; Wilkins; pp 747&#x2013;794.</Citation></Reference><Reference><Citation>Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86599</ArticleId><ArticleId IdType="pubmed">10790107</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AJ, Martin DA, Karabatsos N, Roehrig JT. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol. 2000;38:1827&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86600</ArticleId><ArticleId IdType="pubmed">10790108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Tsai WY, Lin SR, Kao CL, Hu SP, King CC, et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 2008; 82:6631&#x2013;6643. 10.1128/JVI.00316-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00316-08</ArticleId><ArticleId IdType="pmc">PMC2447043</ArticleId><ArticleId IdType="pubmed">18448542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232&#x2013;1239. 10.3201/eid1408.080287</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1408.080287</ArticleId><ArticleId IdType="pmc">PMC2600394</ArticleId><ArticleId IdType="pubmed">18680646</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis. 2005;5:137&#x2013;145. 10.1089/vbz.2005.5.137</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vbz.2005.5.137</ArticleId><ArticleId IdType="pubmed">16011430</ArticleId></ArticleIdList></Reference><Reference><Citation>van Meer MPA, M&#xf6;gling R, Klaasse J, Chandler FD, Pas SD, van der Eijk AA, et al. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol. 2017;92:25&#x2013;31. 10.1016/j.jcv.2017.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.001</ArticleId><ArticleId IdType="pubmed">28505571</ArticleId></ArticleIdList></Reference><Reference><Citation>Felix AC, Souza NCS, Figueiredo WM, Costa AA, Inenami M, da Silva RMG, et al. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol. 2017;89:1477&#x2013;1479. 10.1002/jmv.24789</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24789</ArticleId><ArticleId IdType="pubmed">28229481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsey NP, Staples JE, Powell K, Rabe IB, Fischer M, Powers AM, et al. Ability to serologically confirm recent Zika virus infection in Areas with varying past incidence of dengue virus infection in the United States and U.S. territories in 2016. J Clin Microbiol. 2017;56:e01115&#x2013;17. 10.1128/JCM.01115-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01115-17</ArticleId><ArticleId IdType="pmc">PMC5744200</ArticleId><ArticleId IdType="pubmed">29093104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronca SE, Murray KO, Nolan MS. Cumulative incidence of West Nile virus infection, continental United States, 1999&#x2013;2016. Emerg Infect Dis. 2019;25:325&#x2013;327. 10.3201/eid2502.180765</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2502.180765</ArticleId><ArticleId IdType="pmc">PMC6346444</ArticleId><ArticleId IdType="pubmed">30666940</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershman MD, Angelo KM, Ritchey J, Greenberg DP, Muhammad RD, Brunette G, Cetron MS, Sotir MJ. Addressing a Yellow Fever Vaccine Shortage&#x2014;United States, 2016&#x2013;2017. MMWR Morb Mortal Wkly Rep. 2017;66:457&#x2013;9. 10.15585/mmwr.mm6617e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6617e2</ArticleId><ArticleId IdType="pmc">PMC5687078</ArticleId><ArticleId IdType="pubmed">28472025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shearer FM, Moyes CL, Pigott DM, Brady OJ, Marinho F, Deshpande A, et al. Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis. Lancet Infect Dis. 2017;17:1209&#x2013;17. 10.1016/S1473-3099(17)30419-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30419-X</ArticleId><ArticleId IdType="pmc">PMC5666204</ArticleId><ArticleId IdType="pubmed">28822780</ArticleId></ArticleIdList></Reference><Reference><Citation>Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, et al. Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection. Science. 2016;353:823&#x2013;826. 10.1126/science.aaf8505</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8505</ArticleId><ArticleId IdType="pubmed">27417494</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol. 2016;17:1102&#x2013;1108. 10.1038/ni.3515</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3515</ArticleId><ArticleId IdType="pmc">PMC4994874</ArticleId><ArticleId IdType="pubmed">27339099</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016;113:7852&#x2013;7857. 10.1073/pnas.1607931113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607931113</ArticleId><ArticleId IdType="pmc">PMC4948328</ArticleId><ArticleId IdType="pubmed">27354515</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanha PM, Nascimento EJ, Cynthia B, Cordeiro MT, de Carvalho OV, de Mendon&#xe7;a LR, et al. Dengue virus (DENV)-specific antibodies enhance Brazilian Zika virus (ZIKV) infection. J Infect Dis. 2017;215:781&#x2013;785. 10.1093/infdis/jiw638</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw638</ArticleId><ArticleId IdType="pmc">PMC5854042</ArticleId><ArticleId IdType="pubmed">28039355</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul LM, Carlin ER, Jenkins MM, Tan AL, Barcellona CM, Nicholson CO, et al. Dengue virus antibodies enhance Zika virus infection. Clin Transl Immunology. 2016;5:e117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5192063</ArticleId><ArticleId IdType="pubmed">28090318</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 2017;356:175&#x2013;180. 10.1126/science.aal4365</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal4365</ArticleId><ArticleId IdType="pmc">PMC5714274</ArticleId><ArticleId IdType="pubmed">28360135</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ . Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 1977;265:739&#x2013;741. 10.1038/265739a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/265739a0</ArticleId><ArticleId IdType="pubmed">404559</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken MK, Gromowski GD, Friberg HL, Lin X, Abbink P, De La Barrera R, et al. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog. 2017;13:e1006487 10.1371/journal.ppat.1006487</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006487</ArticleId><ArticleId IdType="pmc">PMC5542404</ArticleId><ArticleId IdType="pubmed">28771605</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoja P, P&#xe9;rez-Guzm&#xe1;n EX, Rodr&#xed;guez IV, White LJ, Gonz&#xe1;lez O, Serrano C, et al. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun. 2017;8:15674 10.1038/ncomms15674</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15674</ArticleId><ArticleId IdType="pmc">PMC5490051</ArticleId><ArticleId IdType="pubmed">28643775</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon A, Gresh L, Ojeda S, Katzelnick LC, Sanchez N, Mercado JC, et al. Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua. PLoS Med. 2019;16:e1002726 10.1371/journal.pmed.1002726</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002726</ArticleId><ArticleId IdType="pmc">PMC6342296</ArticleId><ArticleId IdType="pubmed">30668565</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Barraquer I, Costa F, Nascimento EJM, Nery N J&#xfa;nior, Castanha PMS, Sacramento GA, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019;363:607&#x2013;610. 10.1126/science.aav6618</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav6618</ArticleId><ArticleId IdType="pubmed">30733412</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies. Emerg Infect Dis. 2017;23:569&#x2013;573. 10.3201/eid2304.161879</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2304.161879</ArticleId><ArticleId IdType="pmc">PMC5367429</ArticleId><ArticleId IdType="pubmed">28322690</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill. 2016; 21:30426 10.2807/1560-7917.ES.2016.21.50.30426</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.50.30426</ArticleId><ArticleId IdType="pmc">PMC5291135</ArticleId><ArticleId IdType="pubmed">28006649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lustig Y, Zelena H, Venturi G, Van Esbroeck M, Rothe C, Perret C, et al. Sensitivity and kinetics of an NS1-based Zika virus enzyme-linked immunosorbent assay in Zika virus-infected travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile. J Clin Microbiol. 2017;55:1894&#x2013;1901. 10.1128/JCM.00346-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00346-17</ArticleId><ArticleId IdType="pmc">PMC5442546</ArticleId><ArticleId IdType="pubmed">28381608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquier C, Joguet G, Mengelle C, Chapuy-Regaud S, Pavili L, Prisant N, et al. Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays. Diagn Microbiol Infect Dis. 2018;90:26&#x2013;30. 10.1016/j.diagmicrobio.2017.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2017.09.001</ArticleId><ArticleId IdType="pubmed">29107414</ArticleId></ArticleIdList></Reference><Reference><Citation>Safronetz D, Sloan A, Stein DR, Mendoza E, Barairo N, Ranadheera C, et al. Evaluation of 5 commercially available Zika virus immunoassays. Emerg Infect Dis. 2017;23:1577&#x2013;1580. 10.3201/eid2309.162043</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2309.162043</ArticleId><ArticleId IdType="pmc">PMC5572859</ArticleId><ArticleId IdType="pubmed">28665268</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Stettler K, Carrera RM, Collado D, Jin X, Zambrana JV, et al. A novel antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci USA. 2017;114:8384&#x2013;8389. 10.1073/pnas.1704984114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704984114</ArticleId><ArticleId IdType="pmc">PMC5547631</ArticleId><ArticleId IdType="pubmed">28716913</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Zambrana JV, Collado D, Garc&#xed;a N, Sabor&#xed;o S, Elizondo D, et al. Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection. J Clin Microbiol. 2018;56:e01785&#x2013;17. 10.1128/JCM.01785-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01785-17</ArticleId><ArticleId IdType="pmc">PMC5824050</ArticleId><ArticleId IdType="pubmed">29305550</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts C, Green T, Hess E, Matys K, Brown MJ, Haupt RM, et al. Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types. Hum Vaccin Immunother. 2014;10:2168&#x2013;2174. 10.4161/hv.29205</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.29205</ArticleId><ArticleId IdType="pmc">PMC4896759</ArticleId><ArticleId IdType="pubmed">25424920</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch HE, Sanchez AM, D'Souza MP, Rountree W, Denny TN, Kalos M, et al. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays. J Immunol Methods. 2014;409:62&#x2013;71. 10.1016/j.jim.2014.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2014.04.011</ArticleId><ArticleId IdType="pmc">PMC4138252</ArticleId><ArticleId IdType="pubmed">24801479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachmann N, Todorova K, Schulze H, Sch&#xf6;nemann C. Luminexand its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion. Transfus Med Hemother. 2013;40:182&#x2013;189. 10.1159/000351459</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351459</ArticleId><ArticleId IdType="pmc">PMC3725018</ArticleId><ArticleId IdType="pubmed">23922543</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SM Jr, Popowitch EB, Levinson KJ, John TM, Lehman B, Rios MB, et al. Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel. J Clin Microbiol. 2018;56: e01885&#x2013;17. 10.1128/JCM.01885-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01885-17</ArticleId><ArticleId IdType="pmc">PMC5971534</ArticleId><ArticleId IdType="pubmed">29643194</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Youn HH, Brites C, Tsai JJ, Tyson J, Pedroso C, et al. Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by combination of three simple serological tests. Clin Infect Dis 2017;65:1829&#x2013;1836. 10.1093/cid/cix672</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix672</ArticleId><ArticleId IdType="pmc">PMC5850648</ArticleId><ArticleId IdType="pubmed">29020159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyson J, Tsai WY, Tsai JJ, Brites C, M&#xe4;ssg&#xe5;rd L, Youn HH, et al. Combination of non-structural protein 1-based enzyme-linked immunosorbent assays can detect and distinguish various dengue virus and Zika virus infections. J Clin Microbiol. 2019;57:e01464&#x2013;18. 10.1128/JCM.01464-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01464-18</ArticleId><ArticleId IdType="pmc">PMC6355536</ArticleId><ArticleId IdType="pubmed">30429254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan G, Gordon A, Avil&#xe9;s W, Ortega O, Hammond SN, Elizondo D, et al. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol. 2009;170:120&#x2013;129. 10.1093/aje/kwp092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwp092</ArticleId><ArticleId IdType="pmc">PMC2700880</ArticleId><ArticleId IdType="pubmed">19435864</ArticleId></ArticleIdList></Reference><Reference><Citation>Narvaez F,* Gutierrez G*, Perez MA, Elizondo D, Nu&#xf1;ez A, Balmaseda A, et al. Evaluation of the Traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis. 2011;5:e1397 10.1371/journal.pntd.0001397</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001397</ArticleId><ArticleId IdType="pmc">PMC3210746</ArticleId><ArticleId IdType="pubmed">22087348</ArticleId></ArticleIdList></Reference><Reference><Citation>Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451&#x2013;459. 10.1056/NEJMoa044333</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa044333</ArticleId><ArticleId IdType="pubmed">16079368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis. 2006;43:1023&#x2013;1030. 10.1086/507635</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/507635</ArticleId><ArticleId IdType="pubmed">16983615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Durbin A, Tsai JJ, Whitehead S, Wang WK. Complexity of neutralization antibodies against multiple dengue viral serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J Virol. 2015;89:7348&#x2013;7362. 10.1128/JVI.00273-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00273-15</ArticleId><ArticleId IdType="pmc">PMC4473561</ArticleId><ArticleId IdType="pubmed">25972550</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Williams KL, Wu YC, Knight S, Balmaseda A, Harris E, et al. Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl Trop Dis. 2013;7:e2451 10.1371/journal.pntd.0002451</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002451</ArticleId><ArticleId IdType="pmc">PMC3777924</ArticleId><ArticleId IdType="pubmed">24069496</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai JJ, Liu CK, Tsai WY, Liu LT, Tyson J, Tsai CY, et al. Seroprevalence of dengue in two districts of Kaohsiung city after the largest dengue outbreak in Taiwan since world war II PLoS Negl Trop Dis. 2018;12:e0006879 10.1371/journal.pntd.0006879</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006879</ArticleId><ArticleId IdType="pmc">PMC6218099</ArticleId><ArticleId IdType="pubmed">30356316</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SJ, Boyle RH, Demarest VL, Woodmansee AN, Kramer LD, Li H, et al. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol. 2003;41:4217&#x2013;4223. 10.1128/JCM.41.9.4217-4223.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.41.9.4217-4223.2003</ArticleId><ArticleId IdType="pmc">PMC193845</ArticleId><ArticleId IdType="pubmed">12958248</ArticleId></ArticleIdList></Reference><Reference><Citation>Namekar M, Kumar M, O'Connell M, Nerurkar VR. Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay. PLoS One. 2012;7:e45851 10.1371/journal.pone.0045851</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045851</ArticleId><ArticleId IdType="pmc">PMC3457982</ArticleId><ArticleId IdType="pubmed">23049879</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J. Immunol. Methods. 1998;221:35&#x2013;41. 10.1016/s0022-1759(98)00170-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-1759(98)00170-7</ArticleId><ArticleId IdType="pubmed">9894896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SJ, Furuya A, Zou J, Xie X, Dupuis AP II, Kramer LD, et al. A multiplex microsphere immunoassay for Zika virus diagnosis. EBioMedicine. 2017;16:136&#x2013;140. 10.1016/j.ebiom.2017.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5474433</ArticleId><ArticleId IdType="pubmed">28094237</ArticleId></ArticleIdList></Reference><Reference><Citation>Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, et al. Birth defects among fetuses and infants of US Women with evidence of possible Zika virus infection during pregnancy. JAMA. 2017;317:59&#x2013;68. 10.1001/jama.2016.19006</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.19006</ArticleId><ArticleId IdType="pubmed">27960197</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden V, Pessoa A, Dobyns W, Barkovich AJ, J&#xfa;nior HV, Filho EL, et al. Description of 13 infants born during October 2015-January 2016 with congenital Zika virus infection without microcephaly at birth&#x2014;Brazil. MMWR Morb Mortal Wkly Rep. 2016;65:1343&#x2013;1348. 10.15585/mmwr.mm6547e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6547e2</ArticleId><ArticleId IdType="pubmed">27906905</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL. Diagnosis of Zika virus infections: challenges and opportunities. J Infect Dis. 2017;216 (suppl_10):S951&#x2013;956. 10.1093/infdis/jix502</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix502</ArticleId><ArticleId IdType="pmc">PMC5853979</ArticleId><ArticleId IdType="pubmed">29267922</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G, Stone M, Busch MP. Arbovirus Diagnostics: From bad to worse due to expanding dengue virus vaccination and Zika virus epidemics. Clin Infect Dis. 2018;66:1181&#x2013;1183. 10.1093/cid/cix972</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix972</ArticleId><ArticleId IdType="pmc">PMC6248677</ArticleId><ArticleId IdType="pubmed">29301009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>